TrialMedical oncology (Northwood, London, England)2022

Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.

Diane K Reyes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.